These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 634508)

  • 1. The workinghman's diet. II. Effect of weight reduction in obese patients with hypertension, diabetes, hyperuricemia and hyperlipidemia.
    Heyden S
    Nutr Metab; 1978; 22(3):141-59. PubMed ID: 634508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
    Fagerberg B; Berglund A; Andersson OK; Berglund G
    J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diet therapy in hypertension, disordered lipid metabolism, diabetes and gout. A dietary plan for all cases].
    Richter WO
    MMW Fortschr Med; 2003 Aug; 145(31-32):25. PubMed ID: 14524066
    [No Abstract]   [Full Text] [Related]  

  • 4. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus.
    Watts NB; Spanheimer RG; DiGirolamo M; Gebhart SS; Musey VC; Siddiq YK; Phillips LS
    Arch Intern Med; 1990 Apr; 150(4):803-6. PubMed ID: 2327840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical training in the prophylaxis and treatment of obesity, hypertension and diabetes.
    Krotkiewski M
    Scand J Rehabil Med Suppl; 1983; 9():55-70. PubMed ID: 6372078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of reducing--revisited.
    Blackburn GL; Read JL
    Postgrad Med J; 1984; 60 Suppl 3():13-8. PubMed ID: 6240029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low energy diet and weight loss on major risk factors, central obesity and associated disturbances in patients with essential hypertension.
    Singh RB; Niaz MA; Bishnoi I; Singh U; Begum R; Rastogi SS
    J Hum Hypertens; 1995 May; 9(5):355-62. PubMed ID: 7623373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Desired and undesired effects of fasting therapy].
    Lageder H
    Hippokrates; 1975 Feb; 46(1):70-85. PubMed ID: 1091607
    [No Abstract]   [Full Text] [Related]  

  • 10. [Does short-term fasting lower the cardiovascular risk in obesity? Effects of the composition of the reducing diet].
    Kolb S; Sailer D
    Fortschr Med; 1983 Sep; 101(35):1550-3. PubMed ID: 6629289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects.
    Sabuncu T; Ucar E; Birden F; Yasar O
    Diabetes Nutr Metab; 2004 Apr; 17(2):103-7. PubMed ID: 15244102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity.
    Miyashita Y; Koide N; Ohtsuka M; Ozaki H; Itoh Y; Oyama T; Uetake T; Ariga K; Shirai K
    Diabetes Res Clin Pract; 2004 Sep; 65(3):235-41. PubMed ID: 15331203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of insulin sensitivity in early diabetes III. The effect of a combined physical training and diet programme on body weight, serum lipids and insulin sensitivity in obese asymptomatic diabetics.
    Ratzmann KP; Zander E; Witt S; Schulz B
    Endokrinologie; 1981 Apr; 77(2):233-41. PubMed ID: 7262046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of modern diet therapy in the prevention of visceral complications in patients with dietary obesity].
    Kadyrova RKh; Shakieva RA; Salkhanov BA
    Vopr Pitan; 1987; (1):16-20. PubMed ID: 3564380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of massive obesity with rice/reduction diet program. An analysis of 106 patients with at least a 45-kg weight loss.
    Kempner W; Newborg BC; Peschel RL; Skyler JS
    Arch Intern Med; 1975 Dec; 135(12):1575-84. PubMed ID: 1200726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
    de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
    Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of quality control indices in moderately hypocaloric Mediterranean diet for treatment of obesity.
    De Lorenzo A; Petroni ML; De Luca PP; Andreoli A; Morini P; Iacopino L; Innocente I; Perriello G
    Diabetes Nutr Metab; 2001 Aug; 14(4):181-8. PubMed ID: 11716286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of a controlled low-energy ('very-low-calorie') diet in the treatment of non-insulin-dependent diabetes and obesity.
    Amatruda JM; Richeson JF; Welle SL; Brodows RG; Lockwood DH
    Arch Intern Med; 1988 Apr; 148(4):873-7. PubMed ID: 3355307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucose tolerance in the course of treating endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH; Gries FA
    Dtsch Med Wochenschr; 1979 Jun; 104(22):808-14. PubMed ID: 456256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.